Home LiteratureArticle Details
PMID: 7625792 Published · ppublish English Comparative Study Journal Article

Evaluation of water-soluble pneumocandin analogs L-733560, L-705589, and L-731373 with mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis.

Antimicrobial agents and chemotherapy ·Vol. 39 ·No. 5 ·1995-05-00 ·Pages 1077-81

Abruzzo GK, Flattery AM, Gill CJ, Kong L, Smith JG, Krupa D, Pikounis VB, Kropp H, Bartizal K

Abstract

The activities of the water-soluble pneumocandin derivatives L-733560, L-705589, and L-731373 were evaluated in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis and were compared with those of commercially available antifungal agents. Pneumocandins are inhibitors of 1,3-beta-D-glucan synthesis. In the aspergillosis model, L-733560 and L-705589 significantly prolonged the survival of DBA/2N mice challenged intravenously with Aspergillus fumigatus conidia. L-733560 and L-705589 exhibited efficacies comparable to that of amphotericin B (AMB) with 90% effective doses of 0.48, 0.12, and 0.36 mg/kg of body weight, respectively. Two mouse models of disseminated candidiasis were used to evaluate these compounds. In both models, mice were challenged intravenously with Candida albicans. In a C. albicans survival model with DBA/2N and CD-1 mice, the efficacy of L-733560 was comparable to that of AMB, while L-731373 and L-705589 were somewhat less active. In a previously described C. albicans target organ kidney assay, the pneumocandin analogs and AMB at doses of > or = 0.09 mg/kg were effective in sterilizing kidneys, while fluconazole and ketoconazole were considerably less active and did not sterilize kidneys when they were used at concentrations of < or = 100 mg/kg. Although orally administered L-733560 showed activity in both candidiasis models, its efficacy was reduced compared with that of parenterally administered drug. In a disseminated cryptococcosis mouse model that measures the number of CFU of Cryptococcus neoformans per gram of brain and spleen, L-733560 at 10 mg/kg was ineffective in reducing the counts in organs, while AMB at 0.31 mg/kg sterilized the organs. These results indicate that the pneumocandins may be beneficial as potent parenterally administered therapeutic agents for disseminated aspergillosis and candidiasis.

MeSH Terms
Animals Anti-Bacterial Agents/pharmacology,therapeutic use Antifungal Agents/therapeutic use Aspergillosis/drug therapy,microbiology Candidiasis/drug therapy,microbiology Cryptococcosis/drug therapy,microbiology Female Mice Mice, Inbred DBA Peptides Peptides, Cyclic/pharmacology
Chemicals
Anti-Bacterial Agents Antifungal Agents L 705589 L 731373 L 733560 Peptides Peptides, Cyclic
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Abruzzo G K
Merck Research Laboratories, Rahway, New Jersey 07065-0900, USA.
Flattery A M
Gill C J
Kong L
Smith J G
Krupa D
Pikounis V B
Kropp H
Bartizal K
References (10)
10 references, click to expand
  1. Resistant fits for some commonly used logistic models with medical application.
    Biometrics. 1982 Jun;38(2):485-98 PMID: 7115876
  2. In vitro and in vivo anti-Candida activity and toxicology of LY121019.
    J Antibiot (Tokyo). 1984 Sep;37(9):1054-65 PMID: 6389460
  3. Use of DBA/2N mice in models of systemic candidiasis and pulmonary and systemic aspergillosis.
    Infect Immun. 1990 May;58(5):1476-8 PMID: 2323826
  4. Amphotericin B: 30 years of clinical experience.
    Rev Infect Dis. 1990 Mar-Apr;12(2):308-29 PMID: 2184499
  5. In vitro evaluation of the pneumocandin antifungal agent L-733560, a new water-soluble hybrid of L-705589 and L-731373.
    Antimicrob Agents Chemother. 1995 May;39(5):1070-6 PMID: 7625791
  6. In vitro antifungal activities and in vivo efficacies of 1,3-beta-D-glucan synthesis inhibitors L-671,329, L-646,991, tetrahydroechinocandin B, and L-687,781, a papulacandin.
    Antimicrob Agents Chemother. 1992 Aug;36(8):1648-57 PMID: 1416847
  7. Pneumocandins from Zalerion arboricola. IV. Biological evaluation of natural and semisynthetic pneumocandins for activity against Pneumocystis carinii and Candida species.
    J Antibiot (Tokyo). 1992 Dec;45(12):1886-91 PMID: 1490879
  8. Synthesis and antifungal activity of novel cationic pneumocandin B(o) derivatives.
    J Med Chem. 1994 Jan 21;37(2):222-5 PMID: 8295208
  9. Increased antifungal activity of L-733,560, a water-soluble, semisynthetic pneumocandin, is due to enhanced inhibition of cell wall synthesis.
    Antimicrob Agents Chemother. 1994 Dec;38(12):2750-7 PMID: 7695257
  10. Systemically administered antifungal agents. A review of their clinical pharmacology and therapeutic applications.
    Drugs. 1992 Jul;44(1):9-35 PMID: 1379913
Article Info
Journal
Antimicrobial agents and chemotherapy
Abbr.
Antimicrob Agents Chemother
ISSN
0066-4804
Published
1995-05-00
Pages
1077-81
Language
English
Region
United States
NLM ID
0315061
PMCID
PMC162686
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]